Quarterly ResultApr 30, 2026, 04:34 PM
MMSI Q1 Net Income +36% to $41.0M; Sales +7.5% to $381.9M
AI Summary
MERIT MEDICAL SYSTEMS INC reported strong first-quarter 2026 financial results with net income increasing significantly by 35.98% to $40.995 million and net sales growing 7.46% to $381.877 million. The company also completed the divestment of its DualCap® product line for $28 million, realizing a pre-tax book gain of $12.5 million. Additionally, the company has transitioned to a single operating segment and adjusted its product categories to Foundational and Therapeutic.
Key Highlights
- Net income increased 35.98% to $40.995 million for Q1 2026 from $30.147 million in Q1 2025.
- Diluted EPS rose 38.78% to $0.68 in Q1 2026 from $0.49 in Q1 2025.
- Net sales grew 7.46% to $381.877 million in Q1 2026 from $355.351 million in Q1 2025.
- Divested DualCap® product line for $28 million, resulting in a $12.5 million pre-tax book gain.
- Foundational product revenue was $255.479 million in Q1 2026, up from $240.382 million.
- Therapeutic product revenue was $126.398 million in Q1 2026, up from $114.969 million.
- Cash and cash equivalents increased to $488.080 million as of March 31, 2026, from $446.404 million.
- No outstanding borrowings under the Amended Fourth A&R Credit Agreement as of March 31, 2026.
Price Impact
More from MMSI